Literature DB >> 25803304

Update on osteoporosis from the 2014 Santa Fe Bone symposium.

E Michael Lewiecki1, John P Bilezikian, Neil Binkley, Didier Hans, Diane Krueger, Paul D Miller, Mary Oates, Elizabeth Shane.   

Abstract

The 2014 Santa Fe Bone Symposium provided a setting for the presentation and discussion of the clinical relevance of recent advances in the fields of osteoporosis and metabolic bone disease. The format included oral presentations of abstracts by endocrinology fellows, plenary lectures, panel discussions and breakout sessions, with ample opportunities for informal discussions before and after scheduled events. Topics addressed in these proceedings included a review of the important scientific publications in the past year, fracture prevention in patients with dysmobility and immobility, fracture liaison services for secondary fracture prevention, management of pre-menopausal osteoporosis, the role of bone microarchitecture in determining bone strength, measurement of microarchitecture in clinical practice and methods to improve the quality of bone density testing. This is a report of the proceedings of the 2014 Santa Fe Bone Symposium.

Entities:  

Keywords:  Controversy; emerging; guidelines; new; osteoporosis; risk; safety; treatment

Mesh:

Year:  2015        PMID: 25803304     DOI: 10.3109/07435800.2015.1005746

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  2 in total

Review 1.  Dysmobility syndrome: current perspectives.

Authors:  Keith D Hill; Kaela Farrier; Melissa Russell; Elissa Burton
Journal:  Clin Interv Aging       Date:  2017-01-16       Impact factor: 4.458

2.  Defining an international cut-off of two-legged countermovement jump power for sarcopenia and dysmobility syndrome.

Authors:  N Hong; E Siglinsky; D Krueger; R White; C O Kim; H C Kim; Y Yeom; N Binkley; Y Rhee; B Buehring
Journal:  Osteoporos Int       Date:  2020-09-07       Impact factor: 4.507

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.